Results 91 to 100 of about 28,155 (204)

Dietary management and feeding considerations of pediatric aerodigestive and upper gastrointestinal motility disorders

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 4, Page 748-760, October 2026.
Abstract Objective Pediatric aerodigestive and upper gastrointestinal (UGI) motility disorders are common and may be associated with compromised nutritional status and decreased quality of life. Traditional dietary recommendations for aerodigestive and UGI motility disorders have been rudimentary and largely based upon experience and common sense ...
Khalil El‐Chammas   +8 more
wiley   +1 more source

Management of ketogenic diet therapy in patients with ileostomy: A report of 2 cases

open access: yesNutrition in Clinical Practice, Volume 41, Issue 5, Page 1514-1520, October 2026.
Abstract This case series explores the feasibility and clinical considerations of implementing the ketogenic diet therapy (KDT) for epilepsy management in patients with ileostomies. Two pediatric patients with medication‐resistant epilepsy and ileostomies continued KDT under clinical supervision.
Braden J. Baker   +5 more
wiley   +1 more source

Nausea and vomiting of pregnancy in relation to fear of childbirth: Evidence from a Finnish cohort

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2005-2011, October 2026.
Moderate or severe nausea and vomiting of pregnancy (NVP) is associated with a higher likelihood of fear of childbirth compared with no or mild NVP. The findings suggest that more severe NVP is linked to a greater psychological burden and may affect women's perception of childbirth.
Anna Murto   +5 more
wiley   +1 more source

Rosemary metabolite carnosic acid opens Kv1.1 via its voltage sensor and corrects Kv1.1‐linked episodic ataxia in mice

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 20, Page 6179-6198, October 2026.
Background and Purpose Episodic ataxia type 1 (EA1) is an autosomal dominant neurological disorder caused primarily by loss‐of‐function mutations in the voltage‐gated potassium channel Kv1.1 (KCNA1). Small molecules that restore Kv1.1 activity hold promise as targeted therapies for EA1, yet current pharmacological strategies remain limited ...
Rían W. Manville   +6 more
wiley   +1 more source

Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 19, Page 5701-5731, October 2026.
Abstract Antipsychotic drugs targeting dopamine receptors have been used to treat schizophrenia for decades, primarily alleviating positive symptoms such as hallucinations and delusions. However, they provide limited benefit for cognitive and negative symptoms—major contributors to poor outcomes—and are frequently associated with significant side ...
Brian J. Morris, Judith A. Pratt
wiley   +1 more source

Quimioterapia y Nutrición

open access: yesPerspectivas en Nutrición Humana, 2000
El tratamiento con quimioterapia produce efectos secundarios deletéreos para la salud y para el estado nutricional de las personas que lo reciben. El conocimiento de la forma como actúan estos medicamentos, al igual que el manejo de las complicaciones ...
Gloria Cecilia Deossa Restrepo
doaj  

Home - About - Disclaimer - Privacy